Search

Your search keyword '"Lightwood, Daniel"' showing total 133 results

Search Constraints

Start Over You searched for: Author "Lightwood, Daniel" Remove constraint Author: "Lightwood, Daniel"
133 results on '"Lightwood, Daniel"'

Search Results

2. CD1a promotes systemic manifestations of skin inflammation

4. Therapeutic Monoclonal Antibodies for Ebola Virus Infection Derived from Vaccinated Humans

7. Epitope determines efficacy of therapeutic anti-Tau antibodies in a functional assay with human Alzheimer Tau

11. Phenotypic determinism and stochasticity in antibody repertoires of clonally expanded plasma cells

12. Phenotypic determinism and stochasticity in antibody repertoires of clonally expanded plasma cells

13. Generation of a single-cell B cell atlas of antibody repertoires and transcriptomes to identify signatures associated with antigen-specificity

14. Phenotypic determinism and stochasticity in antibody repertoires of clonally expanded plasma cells

15. B cell clonal expansion is correlated with antigen-specificity in young but not old mice

16. The rapid generation of recombinant functional monoclonal antibodies from individual, antigenspecific bone marrow-derived plasma cells isolated using a novel fluorescence-based method

17. Cyto-Mine: An Integrated, Picodroplet System for High-Throughput Single-Cell Analysis, Sorting, Dispensing, and Monoclonality Assurance

18. Antibody-mediated degradation of 4R-tau restores mitochondrial membrane polarization in human induced pluripotent stem cell-derived neurons with the MAPT10+16 mutation

19. Synaptic autoimmunity: new insights into LGI1 antibody-mediated neuronal dysfunction

22. Distinctive binding properties of human monoclonal LGI1 autoantibodies determine pathogenic mechanisms

23. Rapid isolation of antigen-specific B-cells using droplet microfluidics

24. Role of proteolysis in determining potency of Bacillus thuringiensis Cry1Ac delta-endotoxin

26. Recognition of Amino Acid Motifs, Rather Than Specific Proteins, by Human Plasma Cell-Derived Monoclonal Antibodies to Posttranslationally Modified Proteins in Rheumatoid Arthritis

27. Symmetric dimethylation of poly-GR correlates with disease duration in C9orf72 FTLD and ALS and reduces poly-GR phase separation and toxicity

28. Recognition of Amino Acid Motifs, Rather Than Specific Proteins, by Human Plasma Cell–Derived Monoclonal Antibodies to Posttranslationally Modified Proteins in Rheumatoid Arthritis

29. Monoclonal Anti-Citrullinated Protein Antibodies Generated from RA-Derived B Cells Recognize Amino Acid Motifs Rather Than Specific Proteins

30. Symmetric dimethylation of poly-GR correlates with disease duration in C9orf72 FTLD and ALS and reduces poly-GR phase separation and toxicity.

31. Efficacy of an Inhaled IL-13 Antibody Fragment in a Model of Chronic Asthma

32. Generation and characterization of a high affinity anti-human FcRn antibody, rozanolixizumab, and the effects of different molecular formats on the reduction of plasma IgG concentration

33. Therapeutic Monoclonal Antibodies for Ebola Virus Infection Derived from Vaccinated Humans

34. MONOCLONAL ACPA ANTIBODIES RECOGNISING A COMMON CITRULLINE MOTIF ARE MAINLY DEPENDENT ON LIGHT CHAIN HYPERMUTATIONS FOR ANTIGEN RECOGNITION

36. 08.24 Monoclonal acpa antibodies recognising a common citrulline motif are mainly dependent on light chain hypermutations for antigen recognition

38. A Mixture of Functionally Oligoclonal Humanized Monoclonal Antibodies That Neutralize Clostridium difficile TcdA and TcdB with High Levels of In Vitro Potency Shows In Vivo Protection in a Hamster Infection Model

39. Development of a therapeutic monoclonal antibody that targets secreted fatty acid–binding protein aP2 to treat type 2 diabetes

40. The rapid generation of recombinant functional monoclonal antibodies from individual, antigen-specific bone marrow-derived plasma cells isolated using a novel fluorescence-based method

41. Corrigendum to “The Discovery, Engineering and Characterisation of a Highly Potent Anti-Human IL-13 Fab Fragment Designed for Administration by Inhalation” [J. Mol. Biol. 425 (2013), 577–593]

42. A Mixture of Functionally Oligoclonal Humanized Monoclonal Antibodies That Neutralize Clostridium difficile TcdA and TcdB with High Levels of In Vitro Potency Shows In Vivo Protection in a Hamster Infection Model

43. Generation of Recombinant Monoclonal Antibodies from Immunised Mice and Rabbits via Flow Cytometry and Sorting of Antigen-Specific IgG+ Memory B Cells.

44. Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength

49. The rapid generation of recombinant functional monoclonal antibodies from individual, antigen-specific bone marrow-derived plasma cells isolated using a novel fluorescence-based method.

50. A Mixture of Functionally Oligoclonal Humanized Monoclonal Antibodies That Neutralize Clostridium difficileTcdA and TcdB with High Levels of In VitroPotency Shows In VivoProtection in a Hamster Infection Model

Catalog

Books, media, physical & digital resources